Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
EV/Core EBITDA

    Back to All Ratios
PAR DRUGS AND CHEMICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 3.559.918.1310.973.91

What is the latest EV/Core EBITDA ratio of PAR DRUGS AND CHEMICALS ?

The latest EV/Core EBITDA ratio of PAR DRUGS AND CHEMICALS is 3.55 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20253.55
Mar20249.91
Mar20238.13
Mar202210.97
Mar20213.91

How is EV/Core EBITDA of PAR DRUGS AND CHEMICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 3.55
-64.18
Mar2024 9.91
21.89
Mar2023 8.13
-25.89
Mar2022 10.97
180.56
Mar2021 3.91 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare EV/Core EBITDA ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹173.5 Cr -10% 36.8% 37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,236.0 Cr -1.8% -3.7% 17.2% Stock Analytics
DIVIS LABORATORIES ₹249,673.0 Cr 3.4% 10.1% 57.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,460.0 Cr 1.6% 0.8% 37.8% Stock Analytics
CIPLA ₹111,484.0 Cr -0.4% -5.6% -11.9% Stock Analytics
DR REDDYS LABORATORIES ₹95,220.3 Cr -1.1% -4.9% -9.9% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

-10%

36.8%

37%

SENSEX

-1.6%

-4.2%

-7.2%


You may also like the below Video Courses